While this Swedish study demonstrated a significant association between baseline platelet count and ED, an 813-patient study treated with ATRA plus daunorubicin from Brazil applied this risk model to predict ED in their population, but platelets did not reach statistical significance in their model [ 35 ].
1
—
—